Florence Atrafi
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
- Co-authors
- Ron H.J. Mathijssen (13 shared papers)Cristianne J.F. Rijcken (9 shared papers)Rob Hanssen (7 shared papers)Ferry A.L.M. Eskens (5 shared papers)Neeltje Steeghs (4 shared papers)Stijn L.W. Koolen (6 shared papers)Peter de Bruijn (5 shared papers)Remy B. Verheijen (2 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Clinical Cancer Research (2 papers)Advanced Drug Delivery Reviews (1 paper)Journal of Chromatography B (1 paper)Cancer Research (1 paper)
- Partner nations
- NetherlandsUnited StatesBelgium
In The Last Decade
Florence Atrafi
18 papers receiving 324 citations
Peers
Comparison fields: 5 of 55
- Biomaterials 112
- Transplantation 10
- Oncology 93
- Gastroenterology 13
- Cancer Research 34
Countries citing papers authored by Florence Atrafi
This map shows the geographic impact of Florence Atrafi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florence Atrafi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florence Atrafi more than expected).
Fields of papers citing papers by Florence Atrafi
This network shows the impact of papers produced by Florence Atrafi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florence Atrafi. The network helps show where Florence Atrafi may publish in the future.
Co-authors
The 25 scholars most cited alongside Florence Atrafi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 47 | |
| 2 | 2018 | 40 | |
| 3 | 2020 | 39 | |
| 4 | 2018 | 38 | |
| 5 | 2018 | 27 | |
| 6 | 2011 | 25 | |
| 7 | 2022 | 24 | |
| 8 | 2017 | 23 | |
| 9 | 2018 | 22 | |
| 10 | 2019 | 13 | |
| 11 | 2021 | 11 | |
| 12 | 2024 | 8 | |
| 13 | 2017 | 4 | |
| 14 | 2019 | 3 | |
| 15 | 2019 | 2 | |
| 16 | 2025 | 1 | |
| 17 | 2025 | 1 | |
| 18 | 2017 | 1 |
About Florence Atrafi
Florence Atrafi is a scholar working on Oncology, Genetics, Biomaterials, Biomedical Engineering and Dermatology, having authored 18 papers that have together received 329 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (7 papers), Nanoparticle-Based Drug Delivery (4 papers), Lung Cancer Research Studies (2 papers), Cancer Genomics and Diagnostics (2 papers), Chemotherapy-related skin toxicity (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Gastrointestinal Tumor Research and Treatment (2 papers) and Neutropenia and Cancer Infections (2 papers). The work is most often cited by research in Biomaterials (112 citations), Transplantation (10 citations), Oncology (93 citations), Gastroenterology (13 citations) and Cancer Research (34 citations). Florence Atrafi has collaborated with scholars based in Netherlands, United States and Belgium. Frequent co-authors include Ron H.J. Mathijssen, Cristianne J.F. Rijcken, Rob Hanssen, Ferry A.L.M. Eskens, Neeltje Steeghs, Stijn L.W. Koolen, Peter de Bruijn, Remy B. Verheijen, Alwin D. R. Huitema and Martijn P. Lolkema. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Advanced Drug Delivery Reviews, Journal of Chromatography B and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.